EFORT

EFORT - European Federation of National Societies of Orthopaedics and Traumatology

EFORT promotes the exchange of experience, knowledge, education and research throughout Europe by:

• Representation of state-of-the-art orthopaedics and musculoskeletal traumatology in Europe.
• Promotion of research, science and training in orthopaedics and traumatology in Europe.
• Exchange of scientific experience and knowledge and the improvement of education and training.
• Formulation of EFORT standards and guidelines for the various areas of activity pursued by our members.

25/11/2025

👩‍⚕️ 👨‍⚕️ Tired of managing IV lines for TXA in your Total Knee Arthroplasty (TKA) patients? 💉 There’s good news for your Enhanced Recovery After Surgery (ERAS) protocols!

📊 A new meta-analysis in EFORT Open Reviews compared oral (PO) TXA vs. intravenous (IV) TXA in TKA patients. The results are clear: Oral TXA is just as effective and safe as IV TXA! 🎉

👉 What does this mean for you?

🔹 Comparable Efficacy: Same control over Hb drop and transfusion rates.

🔹 Comparable Safety: No significant difference in complications.

🔹 The Big Win: Oral TXA is much cheaper (up to 90% cost savings!) and easier to administer. 💊

Switching to oral TXA 2 hours pre-op could simplify your blood management without sacrificing safety or efficacy. Check out the evidence! 👇

🔗 Read the full article here: https://bit.ly/EOR102506

🧑‍🎓Author(s): Yongjian Wang, Xinyu Na, Tong Chen, Lingqin Huang, Cong Chen, and Hainan Hong

🔔 Stay at the forefront of orthopaedic research – subscribe to EOR updates: https://bit.ly/eor_subscribe

24/11/2025

🚩Last Chance ⏰ Last call!

➡️ Only a few hours left to register for our FREE EFORT webinar on "Cell-free products in OA: secretome, EVs and exosomes."

📅Today Monday, 24 Nov, 19:00 CET.
👉 Don't miss this chance to learn from top experts!
🔗 Register now for FREE! https://efort.webinargeek.com/20251124

21/11/2025

Got a patient with advanced knee OA and suddenly severe pain? 🤔 Don't miss a Proximal Tibial Stress Fracture! It's a tricky diagnosis, often hiding behind OA symptoms.

📰 A new EFORT Open Reviews article dives into this "vicious cycle" of varus deformity, OA, and fracture. 😵

❓ The BIG question: How do you fix the fracture AND the arthritis in one go? 🛠️

🔹 Forget Conservative Rx: It leads to stiffness and nonunion. One-stage TKA is the way to go! 🎯

🔹 The Power of PFR: For stiff nonunions or malunions, adding Partial Fibular Resection to the long-stem TKA is a game-changer. It helps compress the fracture and correct the alignment without exposing the fracture site (which risks wound necrosis!). 🔪

👉 Check out the full paper for the stepwise management approach, including the Mullaji and Mittal classifications! 👇

🔗 Read the full article here: https://bit.ly/EOR102505

🧑‍🎓Author(s): Farzad Vosoughi, Mohammad Ayati Firoozabadi, and Seyed Mohammad Javad Mortazavi

🔔 Stay at the forefront of orthopaedic research – subscribe to EOR updates: https://bit.ly/eor_subscribe

21/11/2025

Congrats to all the candidates who passed the EBOT written exam! 🎉 You've made it to the final stage, and we're so proud of all your hard work!

👉 The EBOT Exam has been a stamp of excellence for over 20 years, and you're so close to earning this amazing title. Remember to take care of yourselves during this last stretch—your well-being is just as important as your preparation. Breathe, believe in your knowledge, and show the examiners what you've got! 💪

➡️ The oral exams are your last step to becoming a Fellow of the European Board of Orthopaedics and Traumatology, and we're cheering you on!

📅 🗺️ Here are the dates and locations for the oral exams:

🔷 EBOT Exam in English: Madrid, 🇪🇸 | 27-28 September ✔️
🔷 EBOT Exam in Turkish (EBOT-TK): Ankara, Türkiye | 25-26 October ✔️
🔷EBOT Exam in Spanish (EBOT-ES): Madrid, 🇪🇸 | 22-23 November

☘️ Best of luck to all candidates! Wishing you all the very best! ✨

🔗 More information: http://www.ebotexam.org/

20/11/2025

🏁Get ready for a first-class congress experience at FYCMA, the stunning venue for EFORT 2026 in Málaga! ✨

👉This isn't your average conference centre. FYCMA offers massive, bright spaces, excellent connectivity to the city, and everything you need to focus on cutting-edge orthopaedic science (04–06 May 2026).

➡️ Easy to get to, easy to navigate, and a perfect backdrop for meeting global peers!
Spots are filling up—don't miss out on the science and the comfort!

🔗 Register Now: https://congress.efort.org/
📍 See the Venue: https://congress.efort.org/the-venue

19/11/2025

Knee surgeons, let's talk about the tricky business of patellar instability! 🦵🔄

The dynamic MPFL reconstruction (dMPFLr) is a go-to for skeletally immature patients, avoiding that risky femoral drill hole near the growth plate. But how effective is it, really? 🤔

📊 A new systematic review and meta-analysis in EFORT Open Reviews has the answer:

🔹 Subjective Scores are Great! 🎉 Patients reported a mean Kujala score of 86.74, similar to the "gold standard" static method.

🔹BUT, The Big Snag: The rate of recurrent instability is 13%! 😱 That's significantly higher than static MPFLR.

🚩 The conclusion? It's a trade-off. It’s safer for growing bones, but has a higher failure rate. Crucial reading before your next MPFL case!

🔗 Read the full article here: https://bit.ly/EOR102504

🧑‍🎓Author(s): Jonas Eck, Guido Schwarzer, Andreas Frodl, Andreas Fuchs, Tayfun Yilmaz, Hagen Schmal, Kaywan Izadpanah, and Markus Siegel

🔔 Stay at the forefront of orthopaedic research – subscribe to EOR updates: https://bit.ly/eor_subscribe

18/11/2025

👩‍⚕️ 👨‍⚕️ Curious about the future of OA treatment? 🤔

👉 Our upcoming EFORT webinar will answer your burning questions about "Cell-free products in OA!"

🚩 You'll learn to:

1️⃣ Understand Exosome basics & how they work.
2️⃣ See how MSC production impacts treatment efficacy.
3️⃣Evaluate real-world safety & clinical results. Get ahead in orthopaedics!

🗓️ FREE to attend! 24 Nov 2025, 19:00 CET
🔗 https://efort.webinargeek.com/20251124

18/11/2025

🙏 Thank you to all who submitted their abstracts for the EFORT Congress Málaga 2026! 🎉

🎉 We received a fantastic response and are excited to begin the review process.

🔎 Our Science Committee is now carefully evaluating each abstract.

📅 ➡️ Notification Date: You will receive your acceptance/rejection notification on Thursday, 29 January 2026.

⚠️ ➡️ Next Steps: Presenting authors must register for the congress by Monday, 16 February 2026, to confirm their spot in the scientific programme.

🌟 We look forward to sharing the results of the review process with you soon! 🤝

❗ Stay tuned and get more information ⬇️
🔗 https://congress.efort.org/abstracts
🔗 https://congress.efort.org/

17/11/2025

🌟 This is it this time!

Today, Monday 17 November 2025, is the final of the extended deadline to submit your abstract for the EFORT Congress 2026.

❗ ⚠️This is your VERY LAST opportunity to have your work considered for presentation at the biggest European platform for orthopaedics and traumatology.

🙏 ➡️ Don't miss out on this key opportunity to contribute to the field.

✍️ Submit your abstract before 23:59 CET today!
🔗 https://scientific.efort.org/efort2026
🔹 https://congress.efort.org/abstract-submission

17/11/2025

Are you still planning Total Knee Arthroplasty (TKA) purely based on a neutral mechanical axis? 🤔 You might be missing 85% of the story!

The new EFORT Open Reviews issue drops a crucial guide on Biplanar Knee Alignment analysis! 📏
Here’s why it matters:

🔹2D vs. 3D: We're moving beyond simple coronal plane (CPAK) models. The Functional Knee Phenotype offers a way more detailed, segmental approach. 🤯

🔹 Sagittal is KEY: You must consider the Posterior Tibial Slope (PTS). Changes here significantly impact PCL function and overall knee stability! 🦵

🔹 Goal: Personalized TKA! By using long-leg weight-bearing films and this stepwise method, you can better replicate the patient's native, pre-arthritic alignment for happier outcomes. ✨

🚩 Don't let outdated planning techniques hold you back! Get the full, standardised method here: 👇

🔗 Read the full article here: https://bit.ly/EOR102503

🧑‍🎓Author(s): Shuhei Hiyama, Reuben P Rao, Tsuneari Takahashi, Jeya Palan, and Hemant Pandit

🔔 Stay at the forefront of orthopaedic research – subscribe to EOR updates: https://bit.ly/eor_subscribe

14/11/2025

📢 🚩 Great news! We have decided to extend the abstract submission deadline for the EFORT Congress 2026 abstarct submission!

⚠️➡️📅 You now have until next Monday 17 November 2025 at 23:59 CET to submit your research.

🖍️ This extension provides a final opportunity for everyone to complete and submit their work.

🙏 🧑‍🎓 Submit your abstract before the new deadline ⬇️
🔗 https://scientific.efort.org/efort2026
🔗 https://congress.efort.org/abstracts
🔗 https://congress.efort.org/

14/11/2025

Got a patient with persistent groin pain that's not FAI? 🤔 You might be looking at Extra-Articular Hip Impingement!

📊 The new EFORT Open Reviews issue drops a great read on three tricky conditions: Subspine, Iliopsoas, and Ischiofemoral Impingement.

👉 Here's the scoop:

🔹Diagnosis is KEY: Clinical signs are vague, so you need that CT 🦴 and MRI 🧘‍♀️ to pinpoint the issue and rule out the lumbar spine or FAI.

🔹 The Problem: Whether it's an enlarged AIIS (SSI), a tight psoas tendon (PI), or a narrowed ischiofemoral space (IFI), these conditions are often missed!

🔹 The Plan: Most cases start with physio, but for those that fail? The article breaks down the surgical options.

Don't let these conditions hide in your differential! Read the full review and boost your diagnostic confidence. 👇

🔗 Read the full article here: https://bit.ly/EOR102502

🧑‍🎓Author(s): Thun Itthipanichpong, Napatpong Thamrongskulsiri, Samarth Venkata Menta, and Anil S Ranawat

🔔 Stay at the forefront of orthopaedic research – subscribe to EOR updates: https://bit.ly/eor_subscribe

Adresse

A-One Business Center
Rolle
1180

Webseite

https://www.efort.org/, https://congress.efort.org/, https://efortopenreviews.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von EFORT erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.